Could a statin save pregnancies? new trial aims to prolong High-Risk pregnancies

NCT ID NCT07098975

Recruiting now Disease control Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau Source: ClinicalTrials.gov ↗

First seen Feb 24, 2026 · Last updated May 15, 2026 · Updated 12 times

Summary

This study tests whether a daily dose of pravastatin, a common heart medication, can safely extend pregnancy in women diagnosed with severe early-onset placental insufficiency (preeclampsia or fetal growth restriction). About 154 pregnant women will receive either pravastatin or a placebo between 24 and 30 weeks of pregnancy. The goal is to see if the drug can delay delivery, reduce complications, and improve long-term health for both mother and baby.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PLACENTAL INSUFFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hospital Clínic de Barcelona
NOT_YET_RECRUITING

Barcelona, Spain
Hospital de la Santa Creu i de Sant Pau
RECRUITING

Barcelona, 08025, Spain

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

INTRAUTERINE GROWTH RESTRICTION (IUGR) PLACENTAL INSUFFICIENCY PREECLAMPSIA (PE) PREECLAMPSIA (PE)